Founded in 2015, Synsea Bio is a pioneer in China's synthetic biology sector, boasting comprehensive and innovative R&D capabilities. We specialize in the research, development, production, and commercialization of biotechnology and related products. Our core technical team comprises distinguished professors and top-tier talents with overseas study experience from Zhejiang University. Synsea Bio has established three proprietary technology platforms: bio-enzyme directed evolution and AI design, metabolic engineering, and biomanufacturing. Through these platforms, we have successfully developed a diverse range of novel products and processes. These are widely applied in high value-added sectors, including bio-based animal nutrition, food and feed additives, chiral drug intermediates, cosmetic raw materials, and enzyme preparations. To date, the company has been granted 21 authorized invention patents. To facilitate the large-scale commercialization of our technological achievements, we have built an 53,360sqm production base in Xianju, ensuring a stable supply of our premium products. The company was consecutively recognized as a National High-Tech Enterprise in 2019, 2022, and 2023. Furthermore, in 2025, we were designated as the Zhejiang Provincial Synthetic Biology High-Tech R&D Center and awarded the title of "Specialized, Refined, Distinctive, and Innovative" Enterprise by Zhejiang Province.

The company's animal nutrition portfolio encompasses bio-oils, vitamins (including 25-hydroxyvitamin D₃ and vitamin A), and pigment series such as astaxanthin. Synsea has established extensive partnerships with leading domestic and international breeding enterprises. Our products have been successfully integrated into the farming of poultry, swine, cattle, sheep, and aquaculture, delivering significant performance improvements.